Meeting
2019 ASCO Annual Meeting
Population-based cancer predisposition testing as a component of newborn screening: A cost-effectiveness analysis.
Authors
Jennifer Yeh
Boston Children's Hospital and Harvard Medical School, Boston, MA
Jennifer Yeh , Natasha K. Stout , Aeysha Chaudhry , Michael Gooch , Pamela McMahon , Kurt D. Christensen , Lisa Diller , Ann C. Wu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 10021)
DOI
10.1200/JCO.2019.37.15_suppl.10021
Abstract #
10021
Poster Bd #
403
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Next generation sequencing reveals targetable mutations in multiple sarcoma histologies.
First Author: Rodney Dixon Dorand Jr.
Poster
2020 ASCO Virtual Scientific Program
Prospective agnostic germline testing in pediatric cancer patients.
First Author: Elise Fiala
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2017 ASCO Annual Meeting
Cost-effectiveness of ovarian cancer screening: An analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) from a U.S. health system perspective.
First Author: Haley Moss